Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Dec. 25, 2011	Dec. 26, 2010
Cash and cash equivalents at beginning of year	$ 27,490	$ 42,691
Operating activities:
Net (loss) income including non-controlling interest	(7,531)	15,620
Adjustments to reconcile net (loss) income including non-controlling interest to net cash provided by operating activities:
Equity in earnings of unconsolidated affiliates	(4,303)	(13,990)
Dividends received from unconsolidated affiliates	2,005	2,532
Depreciation and amortization expense	13,468	13,466
Net loss on sale of assets	63	53
Loss on extinguishment of debt	462	1,144
Non-cash compensation expense	1,395	737
Loss on previously held equity interest in Repreve Renewables, LLC	3,656
Deferred income taxes	(575)	234
Other	(8)	(20)
Changes in assets and liabilities, excluding effects of foreign currency adjustments:
Receivables, net	12,130	10,729
Inventories	14,381	(9,953)
Other current assets and income taxes receivable	(1,561)	540
Accounts payable and accrued expenses	(19,830)	(7,618)
Income taxes payable	550	1,047
Net cash provided by operating activities	14,302	14,521
Investing activities:
Capital expenditures	(3,259)	(13,324)
Investments in unconsolidated affiliates	(360)	143
Acquisition of controlling interest in Repreve Renewables, LLC, net of cash acquired	(356)
Proceeds from sale of assets	181	185
Proceeds from return of split dollar life insurance premiums	14	3,241
Net cash used in investing activities	(3,780)	(9,755)
Financing activities:
Payments of notes payable	(10,288)	(15,862)
Payments on revolving credit facility	(92,400)	(77,225)
Proceeds from borrowings on revolving credit facility	92,800	77,225
Proceeds from stock option exercises	60	68
Purchase and retirement of Company stock		(2)
Debt financing fees		(825)
Contributions from non-controlling interest	120
Net cash used in financing activities	(9,708)	(16,621)
Effect of exchange rate changes on cash and cash equivalents	(3,627)	2,349
Net decrease in cash and cash equivalents	(2,813)	(9,506)
Cash and cash equivalents at end of period	$ 24,677	$ 33,185